Improving Quality of Life (QOL) measurement for melanoma patients and their families

Not Applicable

Completed

• Conditions: Quality of Life (QOL) of melanoma patients and their families; Cancer - Malignant melanoma

• Registration Number: ACTRN12609000344291
• Lead Sponsor: Melanoma and Skin Cancer Trials

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-05-25
• Study Completion: 2010-12-31
• Last Update Posted: 27 December 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1060

Inclusion Criteria

i) All melanoma patients attending clinics at Sydney Melanoma Unit (Melanoma Institute Australia), Sydney Cancer Centre (Royal Prince Alfred Hospital) and Westmead Cancer Care Centre (Westmead Hospital)

ii) Participants must have sufficient English fluency

Exclusion Criteria

i) Patients with current major psychiatric disturbance or mental illness

ii) Participants with insufficient English fluency

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Generation and validation of new items for a melanoma-specific quality of life (QOL) instrument. The focus group interviews from the first part of the study will collect qualitative data on quality of life (QOL) isssues from patients and their family members. An interview template would be used to prompt discussions on quality of life (QOL) topics. Responses would be digitally recorded for transcription and qualitative analysis by the Biostatistician.[6 months post-focus group interviews]

Secondary Outcome Measures

Name	Time	Method
one[None]